Clinical Trials List
Protocol NumberMK-0663-097
Not yet recruiting
2009-09-25 - 2010-04-25
Phase III
Terminated3
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Hung-Cheng Lai Division of Obstetrics & Gynecology
- 武國璋 Division of Obstetrics & Gynecology
- 鄭澄寰 Division of Anesthesia
- 張正昌 Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 邱健泰 Division of Obstetrics & Gynecology
- Huei-Jean Huang Division of Obstetrics & Gynecology
- Ting-Chang Chang Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
396 participants
